Mirion Technologies (STU:55I0) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:55I0 Mirion Technologies Inc STU:55I0
52 GF Score
Price €12.75
GF Value €12.99
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Mirion Technologies Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

STU:55I0
52GF Score
Mirion Technologies Inc STU:55I0
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mirion Technologies (STU:55I0) Overvalued in 2026?

Based on GuruFocus' analysis, Mirion Technologies stock appears to be undervalued. The current stock price of €12.75 is trading 1.9% below its estimated GF Value™ of €12.99. GuruFocus considers Mirion Technologies to be Fairly Valued.

Key valuation signals for STU:55I0:

  • Dividends Received:
  • GF Value™: €12.99 vs. price of €12.75 (1.9% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the STU:55I0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mirion Technologies Business Description

Other Exchanges MIR:USAMIR:Mexico
Address 1218 Menlo Drive, Atlanta, GA, USA, 30318
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
52GF Score

Get the complete analysis for STU:55I0

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.75
Price
€12.99
GF Value